Speakers
Salah Hammouche
Peter Harris
Dr Katharine Halliday
Keynote Presentation
2:05-2:20 The Gwen Fish Lecture 2024: AI in Radiology and Oncology - Dr Kathharine Halliday (Introduced by Keith Tucker)
2:20-2:30 The Microport Lecture: How to Leverage Registries to Apply AI for TJR Safety Surveillance?” - Jing Xie
2:30-2:38 Experiences from other countries. USA - Tom Harte (Moderator Cat Kelly)
Dr. Salah Hammouche is a orthopaedic surgeon, biomedical engineer, and clinical AI innovator whose career seamlessly integrates medicine, engineering, and artificial intelligence. Currently undertaking an ACGME-accredited Sports Medicine Fellowship at MedStar Health – Georgetown University in Washington, D.C., Dr. Hammouche has performed over 3,000 orthopaedic procedures across five Level 1 trauma centers and prestigious institutions. He holds triple board certifications from the Royal College of Surgeons of England (FRCS T&O), the European Board of Orthopaedics and Traumatology (FEBOT), and the International Society of Orthopaedic Surgery and Traumatology (SICOT Dip. Ortho).
Dr. Hammouche earned his PhD in Biomedical Engineering at the University of Leeds, where he conducted groundbreaking research in orthopaedic implant wear and tribology, developing ISO-compliant testing methods and collaborating with industry leaders like Johnson & Johnson. His academic contributions extend to 35 peer-reviewed publications and over 40 international presentations, earning recognition as a finalist for the Orthopaedic Research Society’s New Investigator Award.
In the field of clinical artificial intelligence, Dr. Hammouche has pioneered the application of AI and machine learning in orthopaedics. As the founder of the award-winning MedTech AI startup ClinicalGuidelines.ai, he leverages advanced transformer-based architectures to revolutionize clinical decision-making and improve healthcare delivery. Dr. Hammouche has contributed to early-phase AI development, ethics, and deployment frameworks with the MONAI Consortium and industry partners such as Bayer, earning accolades including the 2024 Government Transformation Award in AI.
Beyond his clinical and research accomplishments, Dr. Hammouche is a passionate advocate for diversity, equity, and inclusion in medicine, recognized nationally for his leadership during the COVID-19 pandemic. His vision is to harness his unique blend of expertise in orthopaedics, engineering, and AI to advance patient care and innovation on a global scale.
Dr. Hammouche’s exceptional interdisciplinary background positions him as a key thought leader in the future of orthopaedic surgery and artificial intelligence integration.
Peter Harris is the Director of Research Science at NielsenIQ, where he leads a global team of Artificial Intelligence researchers. NielsenIQ is a multinational company dedicated to understanding consumer behaviour worldwide. In addition to his role at NielsenIQ, Peter serves as an AI consultant for the NHS, leveraging advanced AI techniques to predict medical conditions from x-rays before they are visible to the human eye. His expertise spans several cutting-edge domains, including Natural Language Processing, Image Classification, Graph Neural Networks, and Generative AI (in collaboration with Microsoft).
Jing Xie is the Senior Vice President, Global Regulatory and Clinical Affairs at MicroPort Orthopedics Inc. She joined MicroPort in September 2021 with over 20 years' experience in leading global teams and developing and executing clinical and regulatory strategies to accelerate market access and market development. Prior to joining MicroPort, Jing held multiple executive level positions, including Sr. Vice President, Global Clinical and Medical Affairs at Smith and Nephew, Vice President, Clinical, Regulatory and Office of Medical Affairs at Medtronic, Vice President, Clinical Affairs, Medical Device Innovation Consortium, Vice President, Global Clinical Affairs at Zimmer Biomet, and Vice President, Global Clinical Research at Biomet. She received her Bachelor of Science in Analytical Chemistry from Xiamen University, her Master of Science in Chemistry and Ph.D. in Materials Science from University of Alabama, and her Master of Science in Computer Science from Purdue University. She also attended the Global Leadership Program at the University of Notre Dame Mendozza College of Business.